Serum Her-2/Neu a potential biomarker in breast cancer patients: correlation with the clinico-pathological parameters
IPMJ-Iraqi Postgraduate Medical Journal. 2015; 14 (4): 555-563
em Inglês
| IMEMR
| ID: emr-177718
ABSTRACT
Background:
Breast cancer is the most common malignancy in women, and a major cause of mortality and morbidity despite the advances in diagnosis and treatment. There is evidence that changes in HER2 protein expressions are associated with breast cancer progression
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Fragmentos de Peptídeos
/
Biomarcadores Tumorais
/
Estudos de Casos e Controles
/
Receptor ErbB-2
/
Antígenos de Neoplasias
Limite:
Adulto
/
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Iraqi Postgrad. Med. J.
Ano de publicação:
2015
Similares
MEDLINE
...
LILACS
LIS